News

Washington, D.C — In a new letter to Advanced Research Projects Agency for Health (ARPA-H) Director Renee Wegrzyn, the House Committee on Energy and Commerce (E&C) and House Committee on Education and the Workforce (E&W) request information on how ARPA-H is ensuring that institutions and individuals involved in the research projects it funds comply with Title VI to ensure a harassment and discrimination-free environment.  This letter comes after a rise in antisemitism on college and university campuses, including Columbia University and the University of California, San Francisco where ARPA-H currently funds research. It is signed by E&C Chair Cathy McMorris Rodgers (R-WA), E&C Subcommittee on Health Chair Brett Guthrie (R-KY), E&C Oversight and Investigations Subcommittee Chair Morgan Griffith (R-VA), E&W Chair Virginia Foxx (R-NC), and E&W Subcommittee on Higher Education and Workforce Development Chair Burgess Owens (R-UT).  KEY EXCERPT :  “Due to ongoing reports of antisemitism across colleges and universities, federal and congressional investigations into potential civil rights violations at these institutions, and an ongoing congressional investigation into HHS’s and NIH’s handling of these concerns at HHS-funded institutions, the Committees are seeking more information about how ARPA-H ensures that those involved in projects it funds comply with Title VI and relevant civil rights laws to ensure a research environment free of harassment and discrimination, especially towards those of Jewish faith and heritage.”  BACKGROUND :  ARPA-H is an independent agency of the U.S. Department of Health and Human Services (HHS) within the National Institutes of Health (NIH).  ARPA-H reports directly to the Secretary of HHS.  In the last year, ARPA-H has funded more than $595 million in research projects through ISOs and BAA with more than $506 million going to universities and research institutions and the rest to companies or organizations. Some of these research projects include:  August 30, 2024: Up to $39.5 million to Columbia University   August 22, 2024: Up to $7 million to the University of Pennsylvania   August 13, 2024: Up to $18.4 million to the University of Illinois Urbana-Champaign  July 10, 2024: Up to $27 million to the Wyss Institute at Harvard University  June 12, 2024: Up to $24 million to Yale University School of Medicine  April 1, 2024: Up to $35 million to the University of California, San Francisco  September 26, 2023: Up to $104 million to Harvard Medical School  September 25, 2023: Up to $26 million to Stanford University  Of the fourteen university-based projects ARPA-H funded in the last year, eleven (including the eight listed above) are at universities that were recently or are currently under federal and/or congressional investigation for potential Title VI violations and/or are being sued in federal court for permitting antisemitic behavior on campus.  Columbia University has been sued in federal court, is currently undergoing several investigations by the U.S. Department of Education Office for Civil Rights, and is undergoing investigation by congressional committees, for complaints of antisemitism.  The Committee on Energy and Commerce is currently investigating the University of California, San Francisco regarding concerns of antisemitism at the university, medical school, and associated medical centers.  The U.S. Department of Education recently closed its investigation into the University of Illinois-Urbana Champaign with a resolution agreement that found the university was not meeting its obligation under Title VI as it relates to complaints of shared ancestry discrimination—including 135 complaints of anti-Jewish discrimination.  CLICK HERE to read the full letter.

Washington, D.C. — House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) issued the following statement after the Government Accountability Office (GAO) confirmed that the Biden-Harris administration is failing to enforce the accuracy and completeness of prices posted under price transparency rules implemented by the former administration. “The American people are facing ever increasing health care costs, yet the Biden-Harris administration is failing to ensure price transparency rules are followed and pricing information is accurate. Americans cannot wait any longer; Congress must act,” said Chair Rodgers. “The House passed the bipartisan Lower Costs, More Transparency Act to build upon and strengthen those rules, which more than 90 percent of Americans support. I will continue working with the Senate to pass this into law to provide patients with the information needed to make the right care decisions for themselves and their loved ones.”  The GAO provided its analysis in response to a November 2022 bipartisan request from then Committee Chair Frank Pallone, Jr., (D-NJ) and then Ranking Member Cathy McMorris Rodgers.  GAO KEY FINDINGS & SELECT QUOTES :  GAO found that the Centers for Medicare and Medicaid Services (CMS) has not taken action to assess the accuracy and completeness of required price disclosures by hospitals and recommended that the CMS Administrator take action to do so.  “CMS has not assessed whether hospital price transparency machine-readable files are sufficiently complete and accurate to support program goals, and accordingly whether additional enforcement actions are needed. According to federal internal control standards, agencies should identify, analyze, and respond to risks related to achieving agency goals.”   [...]   "The Administrator of CMS should assess whether hospital price transparency machine-readable files are sufficiently complete and accurate to be usable for supporting CMS’s program goal and implement any additional cost-effective enforcement activities as needed. Such an assessment could include soliciting stakeholder feedback or conducting a study of hospital file completeness and accuracy.”   LOWER COSTS, MORE TRANSPARENCY ACT :  After conducting bipartisan oversight of the transparency rule in the 117th Congress, Chair Rodgers led the bipartisan Lower Costs, More Transparency Act through regular order, culminating in the House passing it with 320 yes votes.  READ :  The House Passed a Long-Needed Health Care Price Transparency Measure   Bipartisan Lower Costs, More Transparency Act Saves Seniors Money, Strengthens Medicare   How the Lower Costs, More Transparency Act Helps Patients   Former Speaker Newt Gingrich: The one health care solution to protect everyone from outrageous medical bills   Chair Rodgers: Health Care Price Transparency Will Make a Meaningful Difference for Patients   Nearly 90 Percent of Americans Support Health Care Price Transparency

Bilirakis-led bill heads to the President’s desk Washington, D.C. — House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) issued the following statement after the Senate passed H.R. 7189, the Congenital Heart Futures Reauthorization Act , unanimously. The bill, led by Rep. Gus Bilirakis (R-FL), previously passed the House unanimously on September 23, 2024, will now be sent to the President’s desk. “With more than 40,000 babies in the United States born with a heart defect each year, Congress answered the American people’s call for action. This bipartisan legislation will support research and education regarding congenital heart disease, as well as the impact heart defects have on individuals throughout every stage of life. I commend Rep. Bilirakis for championing this effort and look forward to the President signing it into law,” said Chair Rodgers . “ As a co-founder of the Congenital Heart Caucus, I’ve become familiar with the struggles patients with congenital heart disease and their families face. Our legislation will bring us one step closer to enhancing better treatment options and improving outcomes for all patients suffering with this condition. We’ve seen that this program yields positive results, and, when it is signed into law, it will help future generations live longer, healthier lives,"  said Congressman Bilirakis . H.R. 7189 reauthorizes and makes improvements to the national congenital heart disease research, surveillance, and awareness program at the CDC through fiscal year 2029. It passed out of the House Energy and Commerce Committee unanimously on March 20, 2024.

Washington, D.C. — In response to a recent finding that top National Institutes of Health (NIH) official Dr. Eliezer Masliah falsified research information, House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA), Subcommittee on Health Chair Brett Guthrie (R-KY), and Subcommittee on Oversight and Investigations Chair Morgan Griffith (R-VA) issued the following statement:  “These findings are deeply troubling and worsen an already growing distrust of the NIH’s scientific research. We expect full transparency with Congress and the public regarding the matter. While Republicans have historically championed the NIH, these types of misconduct—coupled with the agency’s lack of cooperation throughout our ongoing COVID-19, MPXV, and sexual harassment investigations—make it difficult to continue such robust support,” said the Chairs. “The responses to the Committee’s NIH reform framework overwhelmingly agreed that a comprehensive review of NIH is needed. We urge experts and stakeholders to continue engaging in constructive discussion to strengthen the NIH, protect taxpayer dollars, and restore trust in government health agencies.”  A Science magazine article also further details the allegations, which were in part confirmed by the NIH. In June 2024, Chair Rodgers unveiled a framework that lays out the current challenges facing the NIH and contains recommendations for reform. CLICK HERE for a one-pager on the framework.  CLICK HERE to read Chair Rodgers opinion piece with House Appropriations Subcommittee on Labor, Health and Human Services, and Education Chair Robert Aderholt (R-AL) regarding the effort.

Revelations come following release of new Committee report Washington D.C. — This weekend, House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) joined Fox & Friends to discuss a new Committee Report on the failures of the Biden-Harris Clean School Bus Program. Highlights and excerpts from the interview below: On Defending American Leadership:   “This is a so-called clean school bus program, and it’s just another part of the Biden-Harris administration’s rush-to-green [agenda]. “We’ve seen them mandating electric vehicles, banning gas stoves, really shutting down American energy.   “But unfortunately, it’s an agenda where the Chinese Communist Party is leading, and America is dependent upon China because they control 90 percent of supply chains for electric batteries.   “This is not the agenda that America needs. We need an agenda of American innovation and free markets, not one where we are dependent upon China. ”  On the Exorbitant Price Tag of Electric Buses:   “Whether it’s Wisconsin or North Dakota or Washington State, they are unreliable.   “We do not have the infrastructure [to support electric school buses], and they are expensive.   “This is a program where the Biden-Harris administration wanted to hand out free school buses across the nation, but unfortunately, they’re not free.   “They’re very expensive, as you mentioned—$381,000.   “These are hard-earned taxpayer dollars that are going to fund part of their so-called green energy agenda.  “There are other clean alternatives, if it really was a clean bus program, that are about $140,000.   “But unfortunately, the administration is mandating this agenda that is expensive, unreliable, and also makes us even more dependent upon the Chinese Communist Party because they control 90 percent of the supply chains.”   CLICK HERE to read more about the Clean School Bus report.

Washington D.C. — Energy and Commerce Republicans are leading to stop the Biden-Harris administration from imposing unaffordable electric vehicle mandates that will jeopardize our auto industry and hand China the keys to our energy future. Members spoke on the House Floor in support of H.J. Res. 136, led by Rep. John James (R-MI), which passed the House with a bipartisan vote of 215-191. The legislation will end the Environmental Protection Agency’s (EPA) unrealistic tailpipe emissions rule, which, by the EPA’s own admission, would effectively require at least two-thirds of all new cars in the United States to be electric by 2032. As Chair Rodgers said , “Over and over again, the Biden-Harris Environmental Protection Agency has doubled down on its radical rush-to-green energy agenda. The EPA’s latest tailpipe emissions rule is not really about reducing air pollution—it’s about forcing Americans to drive electric vehicles.” Don’t miss these key moments from E&C Republicans:

Washington, D.C. — House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) issued the following statement after the House passed nine health bills:  “These bipartisan bills will help improve the health and wellbeing of the American people, including individuals battling Alzheimer’s and children suffering from rare diseases, as well as those living with a disability. I’m grateful to my Energy and Commerce colleagues for moving the bills through regular order and will work to see them signed into law.”  BACKGROUND :  H.R. 8108 – To amend title XIX of the SSA to add a Medicaid State plan requirement with respect to determination of residency of certain individuals serving in Armed Forces:   Led by Reps. Jen Kiggans (R-VA) and Marcy Kaptur (D-OH)  Requires States to continue to provide Medicaid coverage for (or retain waiting list placement for) active-duty military families who are receiving home and community-based services (or are on the waitlist to receive such services) in the event that the family moves out of state for military relocation.  Passed the House unanimously.  Passed out of the House Energy and Commerce Committee unanimously on September 18, 2024.  S. 133 – NAPA Reauthorization Act :  Led by Senator Susan Collins (R-ME)  Reauthorizes and makes improvements to the National Alzheimer’s Project including expanding the membership of the project’s advisory council.   Passed the House unanimously.  House companion (H.R. 619), led by Reps. Paul Tonko (D-NY) and Chris Smith (R-NJ), passed out of the House Energy and Committee unanimously on March 20, 2024.  S. 134 – Alzheimer’s Accountability and Investment Act :  Led by Senator Susan Collins (R-ME)  Requires the NIH to continue to submit an annual budget estimate to Congress to achieve the initiatives and goals included in the National Plan to Address Alzheimer’s Disease.  Passed the House unanimously.  House companion (H.R. 620), led by Reps. Chris Smith (R-NJ) and Paul Tonko (R-NY), passed out of the House Energy and Commerce Committee unanimously on March 20, 2024.   H.R. 6829 – HEARTS Act :  Led by Rep. Frank Pallone, Jr. (D-NJ)  Promotes student access to AEDs and CPR in schools, including educational materials, training programs, and equipment.  Passed the House unanimously.  Passed out of the House Energy and Commerce Committee unanimously on March 20, 2024.  H.R. 3884 – Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act :  Led by Reps. Michael Burgess, M.D., (R-TX) and Danny Davis (D-IL)  Reauthorizes programs and activities under the CDC and the Health Resources and Services Administration (HRSA) aimed to support research, prevention, and treatment for sickle cell disease and other heritable blood disorders through fiscal year 2028.  Passed the House unanimously.  Passed out of the House Energy and Commerce Committee unanimously on July 19, 2023.  H.R. 2706 – Charlotte Woodward Organ Transplant Discrimination Prevention Act :  Led by Reps. Kat Cammack (R-FL) and Debbie Dingell (D-MI)  Prohibits health care providers and other entities from denying or restricting an individual's access to organ transplants solely based on an individual's disability, except in limited circumstances.  Passed the House unanimously.  Passed out of the House Energy and Commerce Committee unanimously on March 20, 2024.  H.R. 5526 – Seniors’ Access to Critical Medications Act :  Led by Reps. Diana Harshbarger (R-TN) and Debbie Wasserman Schultz (D-FL)  Amends the physician self-referral law to permit Medicare patients to receive prescription drugs via caregivers picking up drugs on the patient’s behalf or via mail or couriers delivering the drug to the patient in instances when a provider prescribes a drug to be dispensed by a pharmacy that falls under the self-referral law’s definition of an in-office ancillary service.  Passed the House unanimously.  Passed out of the House Energy and Commerce Committee unanimously on June 12, 2024.  H.R. 3433 – Give Kids a Chance Act :  Led by Reps. Michael McCaul (R-TX) and Anna Eshoo (D-CA)  R eauthorizes the Food and Drug Administration (FDA) rare pediatric disease priority review voucher (PRV) program through fiscal year 2029.  Requires the FDA to establish an office in an Abraham Accord country.  Allows the Secretary of Health and Human Services to collect registration fees and distribute these fees to support the operation of Organ Procurement and Transplantation Network.  Passed the House unanimously.  Passed out of the House Energy and Commerce Committee unanimously on September 18, 2024.  H.R. 7189 – Congenital Heart Futures Reauthorization Act :  Led by Reps. Gus Bilirakis (R-FL) and Darren Soto (FL)  Reauthorizes and makes improvements to the national congenital heart disease research, surveillance, and awareness program at the CDC through fiscal year 2029.  Passed the House unanimously.  Passed out of the House Energy and Commerce Committee unanimously on March 20, 2024. 

H.R. Res 136 ends the Biden-Harris EPA’s de facto EV mandate Washington D.C. — House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) spoke on the House Floor today in support of H.J. Res 136, which will end the Environment Protection Agency’s (EPA) unreasonable tailpipe emissions rule. Her prepared remarks are below: “I rise in strong support of H.J. Res. 136, led by Energy and Commerce Republican Member John James. “Over and over again, the Biden-Harris Environmental Protection Agency has doubled down on its radical rush-to-green energy agenda. “The EPA’s latest tailpipe emissions rule is not really about reducing air pollution—it’s about forcing Americans to drive electric vehicles. “By the EPA’s own estimation, the new rule will effectively require at least two-thirds of all new cars in the United States to be 100 percent electric by 2032—not hybrids, not plug-in hybrids, not hydrogen, not any other clean technology. “This unreasonable rule is just another example of how the Biden-Harris administration’s rush-to-green agenda is handing China the keys to America’s energy future, jeopardizing our auto industry, and forcing people to buy unaffordable EVs they do not want. “Here are the facts: In May, the average fully electric model was $17,326 more expensive than the average gas-burning compact crossover. “At the beginning of this year, nearly 5,000 American car dealers sent a letter to the President demanding he 'hit the brakes' on the EPA’s unrealistic agenda after EVs stacked up on their car lots. “And recently, J.D. Power cut its projected sales of EVs by 25 percent—citing increased competition in the market for gasoline-powered vehicle alternatives. “Despite all of this, the Biden-Harris EPA has continued its de facto EV mandates, undeterred by the reality of what Americans actually want. “Instead of forcing Americans to spend more money on vehicles that they don’t want to buy—on vehicles that only advance a political agenda—let's get back to the work of making sure that people have access to affordable, reliable, and functional means of transportation. “To ensure Americans drive what vehicle best suits their needs, vote YES on H.J. Res 136 to put an end to the EPA’s unreasonable tailpipe emissions rule.”

Letter comes following allegation student was delayed care due to Israeli heritage Washington, D.C. — In a new letter to Columbia University Interim President Katrina Armstrong, the House Committee on Energy and Commerce (E&C) and House Committee on Education and the Workforce (E&W) are demanding answers regarding ongoing and pervasive acts of antisemitic harassment and intimidation at the University and its associated medical school and centers. The letter, signed by E&C Chair Cathy McMorris Rodgers (R-WA), E&C Subcommittee on Health Chair Brett Guthrie (R-KY), E&C Oversight and Investigations Subcommittee Chair Morgan Griffith (R-VA), E&W Chair Virginia Foxx (R-NC), and E&W Subcommittee on Higher Education and Workforce Development Chair Burgess Owens (R-UT) requests that Columbia University respond to the Committees’ questions by no later than October 2, 2024.  It is part of Speaker Mike Johnson’s (R-LA) House-wide  effort  to crack down on antisemitism on college campuses.  KEY EXCERPTS : “A report from the Columbia University Antisemitism Task Force highlighted how the hostility on Columbia University campuses had spilled over into the medical center and medical services as well. For example, an Israeli student reported that when she went to health services in July 2024, no one came into the room to see her, and she overheard a discussion between two health care professionals in another room in which one said they would not treat her because she was Israeli. She sat in the room for another ten minutes until someone finally came to address her health needs.”  [...]  “Failing to comply with basic safety protections for members of the Columbia University community and to respond appropriately to and prevent harassment and discrimination, no matter the cause, may be grounds to withhold federal funds from the university and its associated medical centers. Congress has an obligation to ensure compliance with Title VI. If Congress determines an institution of higher education is in violation, it may consider rescinding research and development funds previously appropriated. Similarly, if Congress determines a medical facility is in violation, it may consider rescinding the right to participate in federal health care programs.”  CLICK HERE to read the full letter.  BACKGROUND :  Beginning on April 17, 2024, an encampment sprung up on Columbia University’s campus with hundreds of protestors and tents.  Banners and signs vandalized the campus—including residence halls—with antisemitic sentiments and even support for the terrorist organization Hamas.  Chants and statements by those within the encampment also supported messages of violence and hate towards Jewish students, with a leader of the encampment filmed stating that, “Zionists don’t deserve to live.”  Professors at Columbia University have also openly made antisemitic and pro-Hamas statements—including more than 100 professors signing a letter in support of the October 7, 2023, terrorist attack by Hamas—adding to the harassment of Jewish students.  An English professor held his classes inside the encampment, despite the fact that it was an uncomfortable and unsafe environment for some of the students in the class, who did not attend.  A prominent rabbi at Columbia University warned Jewish students to remain off-campus during the end of the academic year in Spring 2024 due to fears that the university and New York City police could not keep students safe.  Jewish students on campus also expressed concerns over their safety on campus and the mental and psychological toll the hostile environment was taking on their ability to work and learn. Despite over 100 arrests, the protests progressed to the occupation of a campus building and physical attacks of Jewish students, leading campus officials to move some classes online for the remainder of the academic year.  Columbia University also has a medical school, as well as several affiliated medical centers. Antisemitism has no place in an institution where students go to learn how to be the next generation of medical professionals caring for patients of all religions and ethnic backgrounds.  An interview with students at Irving Medical Center, where Columbia University’s medical school is housed, emphasized the extent to which Jewish students felt excluded and unable to openly identify as Jewish or express their Jewish identity on campus.  A nursing student, for example, stated that the sheer number of antisemitic policy violations that are minimized and go unpunished have made the behavior a norm and that the “Columbia nursing [school] is not a place for Jews.”